JP2010142226A5 - - Google Patents

Download PDF

Info

Publication number
JP2010142226A5
JP2010142226A5 JP2009285970A JP2009285970A JP2010142226A5 JP 2010142226 A5 JP2010142226 A5 JP 2010142226A5 JP 2009285970 A JP2009285970 A JP 2009285970A JP 2009285970 A JP2009285970 A JP 2009285970A JP 2010142226 A5 JP2010142226 A5 JP 2010142226A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
acid sequence
amino acid
positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009285970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010142226A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010142226A publication Critical patent/JP2010142226A/ja
Publication of JP2010142226A5 publication Critical patent/JP2010142226A5/ja
Withdrawn legal-status Critical Current

Links

JP2009285970A 2002-10-29 2009-12-17 ルツォーミアロンギパルピスポリペプチドおよび使用方法 Withdrawn JP2010142226A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42230302P 2002-10-29 2002-10-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004548595A Division JP2006516187A (ja) 2002-10-29 2003-10-29 ルツォーミアロンギパルピスポリペプチドおよび使用方法

Publications (2)

Publication Number Publication Date
JP2010142226A JP2010142226A (ja) 2010-07-01
JP2010142226A5 true JP2010142226A5 (cg-RX-API-DMAC7.html) 2010-10-07

Family

ID=32230337

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004548595A Pending JP2006516187A (ja) 2002-10-29 2003-10-29 ルツォーミアロンギパルピスポリペプチドおよび使用方法
JP2009285970A Withdrawn JP2010142226A (ja) 2002-10-29 2009-12-17 ルツォーミアロンギパルピスポリペプチドおよび使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004548595A Pending JP2006516187A (ja) 2002-10-29 2003-10-29 ルツォーミアロンギパルピスポリペプチドおよび使用方法

Country Status (10)

Country Link
US (6) US7485306B2 (cg-RX-API-DMAC7.html)
EP (2) EP2085467B1 (cg-RX-API-DMAC7.html)
JP (2) JP2006516187A (cg-RX-API-DMAC7.html)
AT (1) ATE429487T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003287267A1 (cg-RX-API-DMAC7.html)
BR (1) BR0315872A (cg-RX-API-DMAC7.html)
DE (1) DE60327366D1 (cg-RX-API-DMAC7.html)
ES (1) ES2447843T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA05004714A (cg-RX-API-DMAC7.html)
WO (1) WO2004039958A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1545575A4 (en) 2002-09-19 2006-04-05 Us Gov Health & Human Serv P. ARIASI POLYPEPTIDE, P. PERNICIOSUS POLYPEPTIDES AND METHOD OF USE
JP2006516187A (ja) * 2002-10-29 2006-06-29 アメリカ合衆国 ルツォーミアロンギパルピスポリペプチドおよび使用方法
US8968749B2 (en) 2006-07-21 2015-03-03 Universidade Federal De Minas Gerais—Ufmg Vaccine composition and immunization method
BRPI0603490B1 (pt) * 2006-07-21 2018-04-24 Universidade Federal De Minas Gerais Vacina recombinante contra a leishmaniose visceral canina
GB0717864D0 (en) * 2007-09-13 2007-10-24 Peptcell Ltd Peptide sequences and compositions
BRPI0915605B8 (pt) * 2008-05-08 2021-09-08 The Government Of The Us Secretary Of The Dept Of Healt & Human Services Vacina de leishmania usando imunógeno salivar de mosca tipo borrachudo
WO2010021940A1 (en) * 2008-08-18 2010-02-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Insect proteins as adjuvants to accelerate the immune response
JP5590986B2 (ja) 2010-06-23 2014-09-17 株式会社シマノ 釣り用リールのワンウェイクラッチ
AR111842A1 (es) 2017-06-02 2019-08-21 Amgen Inc Antagonistas de péptido pac1

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4444487A (en) 1979-07-02 1984-04-24 Xerox Corporation Multiple-flash fuser
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
DE3584341D1 (de) 1984-08-24 1991-11-14 Upjohn Co Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US4745055A (en) 1985-05-07 1988-05-17 California Biotechnology Inc. Fused protein for enzyme immunoassay system
ATE143052T1 (de) 1986-07-07 1996-10-15 Centocor Inc Chimärisches murine-mensch-immunoglobulin, spezifisch für tumorassoziertes 17-1a antigen
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
NZ221790A (en) 1986-09-12 1990-07-26 Genentech Inc Method for the continuous production of a heterologous protein in a eukaryotic host cell
IL84154A0 (en) 1986-10-16 1988-03-31 Microgenesys Inc Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
GB8626412D0 (en) 1986-11-05 1986-12-03 Clark M R Antibodies
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
DE3743138A1 (de) 1987-12-18 1989-09-14 Mayr Christian Gmbh & Co Kg Schleifringlose, elektromagnetische ueberlastkupplung
JP2955759B2 (ja) 1988-07-20 1999-10-04 セゲブ・ダイアグノスティックス・インコーポレイテッド 核酸配列を増幅及び検出する方法
CA2003300A1 (en) 1988-11-21 1990-05-21 Franklin Volvovitz Skin test and test kit for aids
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5397772A (en) * 1989-06-29 1995-03-14 The President And Fellows Of Harvard College Vasodilatory peptides from the salivary gland of the sand fly Lutzomyia longipalpis
US5270202A (en) 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US5427930A (en) 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
DE69030172T2 (de) 1990-01-26 1997-06-19 Immunomedics Inc Impfstoffe gegen Krebs und Infektionskrankheiten
JP3602530B2 (ja) 1991-03-07 2004-12-15 ヴァイロジェネティクス コーポレイション 遺伝子操作したワクチン菌株
US5709860A (en) 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
US5585103A (en) 1991-07-25 1996-12-17 Idec Pharmaceutical Corporation Induction of cytotoxic T-lymphocyte responses
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US5662907A (en) 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
CA2142007C (en) 1992-08-11 2007-10-30 Robert Glen Urban Immunomodulatory peptides
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
ES2198420T3 (es) 1993-09-03 2004-02-01 Mcgill University Genes y proteinas de (leishmania) expresados diferencialmente.
FR2712603B1 (fr) 1993-11-18 1996-02-09 Centre Nat Rech Scient Virus recombinants, préparation et utilisation en thérapie génique.
US5529780A (en) 1994-03-30 1996-06-25 Virogenetics Corporation Nucleotide and amino acid sequences of canine herpesvirus gB and gC
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
DK0776376T3 (da) 1994-07-15 2002-02-18 Organon Teknika Bv Anvendelse af RNA-polymerase til forbedring af en nucleinsyreamplifikationsproces
CA2214029A1 (en) 1995-04-25 1996-10-31 Magda Marquet Single-vial formulations of dna/lipid complexes
AT402203B (de) 1995-06-13 1997-03-25 Himmler Gottfried Dipl Ing Dr Verfahren zur transkriptionsfreien amplifizierung von nucleinsäuren
EP0803573A1 (en) 1996-04-25 1997-10-29 Gesellschaft für Biotechnologische Forschung mbH (GBF) Polycistronic expression construct with cytokines for multivalent vaccines
FR2750865B1 (fr) 1996-06-27 1998-12-04 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
US6156567A (en) 1996-07-03 2000-12-05 Merial Truncated transcriptionally active cytomegalovirus promoters
US6090393A (en) 1996-07-03 2000-07-18 Merial Recombinant canine adenoviruses, method for making and uses thereof
DE69740033D1 (de) 1996-07-03 2010-12-09 Merial Inc Rekombinanter hunde-adenovirus 2 (cav2), welcher exogene dna enthält
CA2268825C (en) 1996-10-11 2006-04-18 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US6017537A (en) 1998-12-18 2000-01-25 Connaught Laboratories, Inc. Formyl methionyl peptide vaccine adjuvant
US6645740B1 (en) 1999-06-10 2003-11-11 Merial Limited Nucleic acids encodings equine GM-CSF
MXPA04000057A (es) 2001-06-19 2005-01-07 Gov Health & Human Serv Vacunas de vector anti-artropodo, metodos de seleccion y usos de las mismas.
EP1545575A4 (en) 2002-09-19 2006-04-05 Us Gov Health & Human Serv P. ARIASI POLYPEPTIDE, P. PERNICIOSUS POLYPEPTIDES AND METHOD OF USE
JP2006516187A (ja) * 2002-10-29 2006-06-29 アメリカ合衆国 ルツォーミアロンギパルピスポリペプチドおよび使用方法

Similar Documents

Publication Publication Date Title
JP2010142226A5 (cg-RX-API-DMAC7.html)
JP2019122392A5 (cg-RX-API-DMAC7.html)
JP2008536483A5 (cg-RX-API-DMAC7.html)
EP2292646A3 (en) Small Streptococcus pyogenes antigens and their use
JP2008525033A5 (cg-RX-API-DMAC7.html)
JP2009268467A5 (cg-RX-API-DMAC7.html)
JP2011523550A5 (cg-RX-API-DMAC7.html)
JP2011004753A5 (cg-RX-API-DMAC7.html)
JP2012522010A5 (cg-RX-API-DMAC7.html)
JP2004512824A5 (cg-RX-API-DMAC7.html)
JP2006187292A5 (cg-RX-API-DMAC7.html)
JP2012512389A5 (cg-RX-API-DMAC7.html)
JP2012515557A5 (cg-RX-API-DMAC7.html)
JP2011517938A5 (cg-RX-API-DMAC7.html)
RU2016133598A (ru) Композиция микобактериального антигена
JP2012506699A5 (cg-RX-API-DMAC7.html)
WO2008084072A3 (en) Protective proteins of s. agalactiae, combinations thereof and methods of using the same
WO2005070958A3 (en) Lawsonia intracellularis subunit vaccines
DK200601181A (da) Fiskevaccine
JP2008541776A5 (cg-RX-API-DMAC7.html)
WO2007064844A3 (en) Anti-viral griffithsin compounds, compositions, and methods of use
WO2010089340A3 (en) Peptides protective against e. faecalis, methods and uses relating thereto
WO2009115508A3 (en) Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
CN102565392A (zh) 一种马链球菌兽疫亚种的酶联免疫检测试剂盒及检测方法
JP2006051019A5 (cg-RX-API-DMAC7.html)